Battle in States on Generic Copies of Biotech Drugs

http://www.nytimes.com/2013/01/29/business/battle-in-states-on-generic-copies-of-biotech-drugs.html?partner=rss&emc=rss

The industry’s lobbying effort could blunt new competition to its products and reduce the savings anticipated in the federal health care overhaul.

Sent by gReader Pro

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s